RE:RE:RE:RE:What happens if Oast does not agree?Ciao, "...with potential game changing results for AV due in the fall..."
It is only a preliminary stage trial to provide insights. We may see if it is anything special. We haven't seen any preclinical data arguing it is. We haven't seen any preclinical data at all for CZO's pill.
“Given the favorable effects of avenanthramide and the increased knowledge on inflammation-based diseases, especially in the cardiovascular area, we believe this study will offer insights in this first-in-class product for a potential new approach for patients,” commented Dr. Jean-Claude Tardif, Director of the Montreal Heart Institute Research Center and Principal Investigator for this clinical trial." news release